INSERM Toulouse

Institut National de la Santé et de la Recherche Medicale (INSERM)

Institut National de la Santé et de la Recherche Medicale (INSERM)
BP 3048, CHU Purpan
31024 Toulouse cedex 3

Principal Investigator

Dr. Anne Cambon-Thomsen

Dr. Anne Cambon-Thomsen

Phone +33-561-145959


Institute Presentation

INSERM (National Institute of Health and Medical research, page.asp?page=1976) is the leading national public research institution in biomedical research in France. Inserm U558 (Toulouse) is a joint research unit between INSERM and the University Paul Sabatier (Toulouse 3), located in the Department of Epidemiology, Health economics and Public Health in the Faculty of Medicine. Anne Cambon-Thomsen heads the team “Genomics and public health: interdisciplinary approach”. The team addresses the implications of genomics for public health, especially issues pertaining to biobanks and to complex disease genetics. It has specifically worked on ethical, legal and social issues of human biobanks and human genetics in the context of research of Public Health Genomics. The team includes 12 persons of different disciplinary background (medicine, genetic epidemiology, public health, philosophy, health law, sociology, health economics, and psychology). An important research objective is to explore the ethical, legal and public health implications when implementing new genomics parameters into health sector and how new dimensions of the information provided by health professionals influences the relations between professionals, patients and their families and the public. The team is involved in several European projects with leadership on ethical and societal issues.

INSERM is in charge of the management of the ELSI aspects of ESGI and transnational access projects as is described in WP7 and participates in networking with biobanks (WP5) and training (WP6).